81
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Circ_0062020 Knockdown Strengthens the Radiosensitivity of Prostate Cancer Cells

, , , , &
Pages 11701-11712 | Published online: 17 Nov 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • de Bono JS, Guo C, Gurel B, et al. Prostate carcinogenesis: inflammatory storms. Nat Rev Cancer. 2020. doi:10.1038/s41568-020-0267-9
  • Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010;116(22):5226–5234. doi:10.1002/cncr.2545620690197
  • Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117–1123. doi:10.1200/JCO.2009.26.013320124165
  • Filson CP, Marks LS, Litwin MS. Expectant management for men with early stage prostate cancer. CA Cancer J Clin. 2015;65(4):265–282. doi:10.3322/caac.2127825958817
  • Rodrigues DN, Butler LM, Estelles DL, de Bono JS. Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol. 2014;232(2):178–184. doi:10.1002/path.427224108540
  • D’Amico AVMJ, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer. JAMA. 2004;292(7):821–827.15315996
  • Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73(3):685–691. doi:10.1016/j.ijrobp.2008.04.06318718725
  • Xia T, Pan Z, Zhang J. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR-4720-3p/TJP1 axis. Cancer Med. 2020. doi:10.1002/cam4.3057
  • Chen H, Liu S, Li M, Huang P, Li X. <p>circ_0003418 Inhibits Tumorigenesis And Cisplatin Chemoresistance Through Wnt/β-Catenin Pathway In Hepatocellular Carcinoma. Onco Targets Ther. 2019;12:9539–9549. doi:10.2147/OTT.S22950731807029
  • Zhang Z, Lin W, Gao L, et al. Hsa_circ_0004370 promotes esophageal cancer progression through miR-1294/LASP1 pathway. Biosci Rep. 2019;39(5). doi:10.1042/BSR20182377
  • Dong Y, Xu T, Zhong S, et al. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p. Life Sci. 2019;239:116984. doi:10.1016/j.lfs.2019.11698431647948
  • Memczak S, Papavasileiou P, Peters O, Rajewsky N, Pfeffer S. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood. PLoS One. 2015;10(10):e0141214. doi:10.1371/journal.pone.014121426485708
  • XD YT W, Liu CL. Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A. Eur Rev Med Pharmacol Sci. 2020;24:5303–5309.32495863
  • Wang X, Wang R, Wu Z, Bai BP. Circular RNA ITCH suppressed prostate cancer progression by increasing HOXB13 expression via spongy miR-17-5p. Cancer Cell Int. 2019;19(1):328. doi:10.1186/s12935-019-0994-831827402
  • Song Z, Zhuo Z, Ma Z, Hou C, Chen G, Xu G. Hsa_Circ_0001206 is downregulated and inhibits cell proliferation, migration and invasion in prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):2449–2464. doi:10.1080/21691401.2019.162686631198063
  • Feng Y, Yang Y, Zhao X, et al. Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death Dis. 2019;10(11):792. doi:10.1038/s41419-019-2028-931624242
  • Shan G, Shao B, Liu Q, et al. circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells. Mol Ther Nucleic Acids. 2020;21:133–146. doi:10.1016/j.omtn.2020.05.00832526477
  • Jin C, Zhao W, Zhang Z, Liu W. Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):3350–3358. doi:10.1080/21691401.2019.164828131387394
  • Martin NE, D’Amico AV. Progress and controversies: radiation therapy for prostate cancer. CA Cancer J Clin. 2014;64(6):389–407. doi:10.3322/caac.2125025234700
  • Yang J, Hao T, Sun J, Wei P, Zhang H. Long noncoding RNA GAS5 modulates α-Solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells. Biomed Pharmacother. 2019;112:108656. doi:10.1016/j.biopha.2019.10865630970507
  • Ghiam AF, Taeb S, Huang X, et al. Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer. oncotarget. 2017;8(3):4668–4689. doi:10.18632/oncotarget.1357627902466
  • Gong P, Zhang T, He D, Hsieh J-T. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer. Radiat Res. 2015;184(6):630–638. doi:10.1667/RR14185.126632856
  • Junqi Liu J, Xue N, Guo Y, Niu K, Gao L, Zhang S. Di Zhao, Ruitai Fan. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway. AGING. 2019;11(24):12412–12427. doi:10.18632/aging.10258031851619
  • Zhu D, Shao M, Yang J, et al. Curcumin Enhances Radiosensitization of Nasopharyngeal Carcinoma via Mediating Regulation of Tumor Stem-like Cells by a CircRNA Network. J Cancer. 2020;11(8):2360–2370. doi:10.7150/jca.3951132127962
  • Zhao M, Xu J, Zhong S, et al. Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells. Oncol Rep. 2019;41(3):1893–1900. doi:10.3892/or.2019.697230664179
  • He Y, Mingyan E, Wang C, Liu G, Shi M, Liu LS. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway. Int J Biol Macromol. 2019;125:116–123. doi:10.1016/j.ijbiomac.2018.11.27330508543
  • Zhu C, Mao X, Zhao H. The circ_VCAN with radioresistance contributes to the carcinogenesis of glioma by regulating microRNA-1183. Medicine. 2020;99(8):e19171. doi:10.1097/MD.000000000001917132080097
  • Wang L, Peng X, Lu X, Wei Q, Chen M, Liu L. Inhibition of hsa_circ_0001313 (circCCDC66) induction enhances the radio-sensitivity of colon cancer cells via tumor suppressor miR-338-3p: effects of cicr_0001313 on colon cancer radio-sensitivity. Pathol Res Pract. 2019;215(4):689–696. doi:10.1016/j.prp.2018.12.03230630646
  • Chen L, Nan A, Zhang N, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019;18(1):13. doi:10.1186/s12943-019-0943-030665425
  • Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. Int J Biol Macromol. 2019;129:227–232. doi:10.1016/j.ijbiomac.2019.01.12730685303
  • Deng L, Liu G, Zheng C, Zhang L, Kang Y, Yang YF. Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression. Gene. 2019;701:146–151. doi:10.1016/j.gene.2019.03.05230922709